Mark Stroh
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
- Biomaterials top 5%
Papers in
- Oncology 16
- Cancer Immunotherapy and Biomarkers 8
- Colorectal Cancer Treatments and Studies 4
-
- Pharmacogenetics and Drug Metabolism 6
- Co-authors
- Raymond C. Stevens (2 shared papers)Moungi G. Bawendi (2 shared papers)John P. Zimmer (2 shared papers)Yinthai Chan (1 shared paper)Dan Gabriel Duda (1 shared paper)Kenneth Stuart Cohen (1 shared paper)Vladimir P. Torchilin (1 shared paper)Dai Fukumura (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (6 papers)Cancer Chemotherapy and Pharmacology (6 papers)American Journal of Therapeutics (4 papers)The AAPS Journal (3 papers)CPT Pharmacometrics & Systems Pharmacology (3 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Mark Stroh
48 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 118
- Microbiology 125
- Biomaterials 220
- Endocrine and Autonomic Systems 81
- Oncology 314
- Endocrinology 63
Countries citing papers authored by Mark Stroh
This map shows the geographic impact of Mark Stroh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stroh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stroh more than expected).
Fields of papers citing papers by Mark Stroh
This network shows the impact of papers produced by Mark Stroh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stroh. The network helps show where Mark Stroh may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Stroh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 368 | |
| 2 | 1996 | 287 | |
| 3 | 1996 | 216 | |
| 4 | 2004 | 200 | |
| 5 | 2016 | 136 | |
| 6 | 2007 | 132 | |
| 7 | 2003 | 64 | |
| 8 | 2009 | 58 | |
| 9 | 2018 | 56 | |
| 10 | 2021 | 53 | |
| 11 | 2016 | 45 | |
| 12 | 2011 | 43 | |
| 13 | 2021 | 32 | |
| 14 | 2018 | 31 | |
| 15 | 2004 | 30 | |
| 16 | 2004 | 27 | |
| 17 | 1998 | 27 | |
| 18 | 2017 | 24 | |
| 19 | 2021 | 22 | |
| 20 | 2013 | 18 |
About Mark Stroh
Mark Stroh is a scholar working on Oncology, Pharmacology, Immunology, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 51 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Pharmacogenetics and Drug Metabolism (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Quantum Dots Synthesis And Properties (4 papers), Immune Cell Function and Interaction (3 papers), Heart Failure Treatment and Management (3 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Microbiology (125 citations), Biomaterials (220 citations), Endocrine and Autonomic Systems (81 citations), Oncology (314 citations) and Endocrinology (63 citations). Mark Stroh has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Raymond C. Stevens, Moungi G. Bawendi, John P. Zimmer, Yinthai Chan, Dan Gabriel Duda, Kenneth Stuart Cohen, Vladimir P. Torchilin, Dai Fukumura, David T. Scadden and Jonathan S. Steckel. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Cancer Chemotherapy and Pharmacology, American Journal of Therapeutics, The AAPS Journal and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.